Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2 ’-deoxycytidine
In this study, we investigated the effect of the DNA demethylation agent 5-AZA-2 ’-deoxycytidine (5-AZA) over HNSCC and its population of cancer stem cells (CSCs) presenting dysfunctional PTEN.
Source: Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics - Category: ENT & OMF Authors: Gabriell Bonifacio Borgato, Gabriel Alvares Borges, Ana Paula Souza, Cristiane Helena Squarize, Rogerio Moraes Castilho Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | ENT & OMF | Genetics | Head and Neck Cancer | HNSCC | Oral Cancer | Pathology | Radiology | Skin Cancer | Squamous Cell Carcinoma | Stem Cell Therapy | Stem Cells | Study